Case Study

GlaxoSmithKline and AIDS drugs in South Africa (B): The settlement

2 pages
February 2005
Reference: IMD-3-1497

The B- part of the cases focuses on the outcome of the lawsuit against the South African government. But the demands from the NGOs keep on coming and Garnier, the CEO of GSK, is faced with some tough decisions to make. Should he allow licensing? How should he deal with parallel importation?

Non-market Competition, Ethics, Pharmaceuticals, AIDS
Africa, South Africa
GlaxoSmithKline, Healthcare, Pharmaceuticals
2001 - 2004
Published Sources
© 2005
Available Languages
Related material
Teaching note
Case clearing houses

Research Information & Knowledge Hub for additional information on IMD publications

Discover our latest research
IMD's faculty and research teams publish articles, case studies, books and reports on a wide range of topics